Literature DB >> 16002917

Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years.

Toru Oga1, Koichi Nishimura, Mitsuhiro Tsukino, Susumu Sato, Takashi Hajiro, Michiaki Mishima.   

Abstract

BACKGROUND: Although exercise capacity is an important outcome measure in patients with COPD, its longitudinal course has not been analyzed in comparison to the change in pulmonary function. PURPOSES: To examine how exercise capacity would deteriorate over time in patients with COPD, and what factors would contribute to it.
METHODS: A total of 137 male outpatients with moderate-to-very-severe COPD were examined. The average age was 69.0 +/- 6.6 years (+/- SD), and the mean postbronchodilator FEV(1) was 45.9 +/- 15.4% predicted. Progressive cycle ergometry and pulmonary function testing were performed at entry, and every 6 months thereafter over 5 years. Due to the presence of missing data, a mixed-effect model analysis was then used to estimate the longitudinal changes in various clinical parameters.
RESULTS: Peak oxygen uptake (Vo(2)), peak minute ventilation (Ve), and peak tidal volume (Vt) during exercise declined significantly over time (p < 0.0001), which was no less rapid than the deterioration in FEV(1). The mean decline rates for peak Vo(2) were 32 +/- 60 mL/min/yr and 0.5 +/- 1.0 mL/min/kg/yr. Multiple regression analysis revealed that the changes in peak Ve, peak Vt, and peak respiratory rates were significant predictors for the change in peak Vo(2).
CONCLUSION: We demonstrated clear evidence of measurable and progressive deterioration in exercise capacity in COPD patients, which was no less rapid than the decline in airflow limitation. Dynamic ventilatory constraints during exercise also deteriorated over time, which most significantly contributed to this exercise capacity deterioration. In addition to pulmonary function, the longitudinal follow-up of exercise capacity is important not to miss the overall deterioration in COPD.

Entities:  

Mesh:

Year:  2005        PMID: 16002917     DOI: 10.1378/chest.128.1.62

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  23 in total

1.  Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?

Authors:  Bram van den Borst; Annemarie Koster; Binbing Yu; Harry R Gosker; Bernd Meibohm; Douglas C Bauer; Stephen B Kritchevsky; Yongmei Liu; Anne B Newman; Tamara B Harris; Annemie M W J Schols
Journal:  Thorax       Date:  2011-07-01       Impact factor: 9.139

2.  SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice.

Authors:  Hongwei Yao; Sangwoon Chung; Jae-woong Hwang; Saravanan Rajendrasozhan; Isaac K Sundar; David A Dean; Michael W McBurney; Leonard Guarente; Wei Gu; Mikko Rönty; Vuokko L Kinnula; Irfan Rahman
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

3.  Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM.

Authors:  Hongwei Yao; Gnanapragasam Arunachalam; Jae-Woong Hwang; Sangwoon Chung; Isaac K Sundar; Vuokko L Kinnula; James D Crapo; Irfan Rahman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

Review 4.  Effects of High-Intensity Interval Training on Pulmonary Function and Exercise Capacity in Individuals with Chronic Obstructive Pulmonary Disease: A Meta-Analysis and Systematic Review.

Authors:  Min Gao; Yangxi Huang; Qianyi Wang; Kouying Liu; Guozhen Sun
Journal:  Adv Ther       Date:  2021-11-18       Impact factor: 3.845

Review 5.  Natural history of emphysema.

Authors:  Omar A Minai; Joshua Benditt; Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

6.  Exposure to cigarette smoke induces overexpression of von Hippel-Lindau tumor suppressor in mouse skeletal muscle.

Authors:  Vladimir T Basic; Elsa Tadele; Ali Ateia Elmabsout; Hongwei Yao; Irfan Rahman; Allan Sirsjö; Samy M Abdel-Halim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

Review 7.  New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.

Authors:  Martijn A Spruit; Emiel F M Wouters
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 8.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

9.  Ascorbate attenuates cycling exercise-induced neuromuscular fatigue but fails to improve exertional dyspnea and exercise tolerance in COPD.

Authors:  Thomas J Hureau; Joshua C Weavil; Simranjit K Sidhu; Taylor S Thurston; Van R Reese; Jia Zhao; Ashley D Nelson; Nathaniel M Birgenheier; Russell S Richardson; Markus Amann
Journal:  J Appl Physiol (1985)       Date:  2020-11-05

10.  Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.

Authors:  Toru Oga; Mitsuhiro Tsukino; Takashi Hajiro; Akihiko Ikeda; Koichi Nishimura
Journal:  Respir Res       Date:  2012-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.